IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 5724 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1338    
    Printed19    
    Emailed0    
    PDF Downloaded1    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 

 ORIGINAL CONTRIBUTION
Year : 1989  |  Volume : 55  |  Issue : 6  |  Page : 375--377

Cutaneous Leishmaniasis: Therapeutic Efficacy of Dapsone in the Commonly Existing Sub-types



Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 28128121

Rights and PermissionsRights and Permissions

In India, contaneous leishmaniasis is confined to the western Thar desert. Epidemiologically, two different forms are seen, viz the rural and the urban forms. The vectors responsible for the transmission in this region are the Phlebotomus papatasi and the Sergentomyia clydei. The efficacy of oral dapsone was evaluated in the commonly existing sub-types of cutaneous leishmaniasis. Ten patients each of the nodular and ulcerative forms of cutaneous leishmaniasis were selected by strict 'clinical and pathological criteria and treated with oral dapsone in a dose of 2 mg per kg body weight daily, for 6 weeks. Seven patients of the nodular variety and all the ten patients in the ulcerative sub-group were cured. No major adverse effects were noted. Review after 6 months revealed no recurrence. in another ten patients taken as controls and not receiving the drug, the lesions showed no significant change.






[PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow